問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberINS-416
Completed

2021-02-01 - 2025-12-26

Phase III

Not yet recruiting6

Terminated6

ICD-10A31.0

Pulmonary mycobacterial infection

ICD-9031.0

Pulmonary diseases due to other mycobacteria

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/07/01

Investigators and Locations

Principal Investigator Chung-Yu Chen Division of Thoracic Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Chih-Hsin Lee Division of Thoracic Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Susan Shin-Jung Lee Division of Infectious Disease

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator 林進國 Division of Thoracic Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Chau-Chyun Sheu Division of Thoracic Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Jia-Yih Feng

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 劉家榮

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Chi-Li Chung

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 唐士恩

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    35 participants

  • Global

    400 participants